ANIP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $23,601,729.53

ANI Pharmaceuticals Insider Trading History Chart

ANI Pharmaceuticals Share Price & Price History

^$56.91

▲ +1.05 (1.88%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

ANI Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/14/2024	Meredith Cook	VP	Sell	250	$57.19	$14,297.50	56,488
9/13/2024	Meredith Cook	VP	Sell	250	$56.82	$14,205.00	56,738
8/13/2024	Meredith Cook	VP	Sell	250	$59.62	$14,905.00	56,988
7/17/2024	Muthusamy Shanmugam	COO	Sell	14,257	$63.16	$900,472.12	635,363
7/15/2024	Muthusamy Shanmugam	COO	Sell	11,000	$63.38	$697,180.00	671,620
7/12/2024	Meredith Cook	VP	Sell	250	$64.91	$16,227.50	58,981
7/1/2024	Chad Gassert	SVP	Sell	20,000	$63.44	$1,268,800.00	193,226
6/21/2024	Muthusamy Shanmugam	COO	Sell	20,000	$58.90	$1,178,000.00	682,620
6/13/2024	Meredith Cook	VP	Sell	250	$63.80	$15,950.00	59,231
6/5/2024	Ori Gutwerg	SVP	Sell	2,985	$67.00	$199,995.00	77,227
6/4/2024	Stephen P Carey	CFO	Sell	5,000	$63.58	$317,900.00	161,968
6/3/2024	Chad Gassert	SVP	Sell	20,000	$64.41	$1,288,200.00	213,226
5/21/2024	Christopher Mutz	Insider	Sell	2,000	$61.61	$123,220.00	83,277
5/20/2024	Muthusamy Shanmugam	COO	Sell	12,855	$61.81	$794,567.55	732,620
5/17/2024	Muthusamy Shanmugam	COO	Sell	5,836	$62.09	$362,357.24	745,475
5/16/2024	Renee P Tannenbaum	Director	Sell	2,000	$63.87	$127,740.00	18,211
5/15/2024	Muthusamy Shanmugam	COO	Sell	14,850	$65.86	$978,021.00	767,770
5/14/2024	Nikhil Lalwani	CEO	Sell	16,669	$66.10	$1,101,820.90	377,505
5/13/2024	Meredith Cook	VP	Sell	250	$67.69	$16,922.50	59,481
5/1/2024	Chad Gassert	SVP	Sell	20,000	$66.62	$1,332,400.00	233,226
4/19/2024	Muthusamy Shanmugam	COO	Sell	16,809	$65.17	$1,095,442.53	782,620
4/17/2024	Muthusamy Shanmugam	COO	Sell	9,520	$65.40	$622,608.00	809,852
4/15/2024	Muthusamy Shanmugam	COO	Sell	7,414	$66.33	$491,770.62	825,206
4/12/2024	Meredith Cook	VP	Sell	250	$67.79	$16,947.50	59,731
4/1/2024	Chad Gassert	SVP	Sell	20,000	$67.25	$1,345,000.00	253,226
3/11/2024	Stephen P Carey	CFO	Sell	7,787	$65.55	$510,437.85	177,712
3/8/2024	Nikhil Lalwani	CEO	Sell	16,292	$67.13	$1,093,681.96	411,629
3/7/2024	James G Marken	SVP	Sell	24,338	$66.37	$1,615,313.06	124,492
3/7/2024	Muthusamy Shanmugam	COO	Sell	15,085	$66.35	$1,000,889.75	842,620
3/6/2024	Nikhil Lalwani	CEO	Sell	28,965	$65.52	$1,897,786.80	444,981
3/5/2024	Muthusamy Shanmugam	COO	Sell	10,093	$65.35	$659,577.55	872,527
2/13/2024	Meredith Cook	VP	Sell	250	$56.04	$14,010.00	36,799
1/22/2024	Muthusamy Shanmugam	COO	Sell	5,692	$55.95	$318,467.40	897,620
1/18/2024	Muthusamy Shanmugam	COO	Sell	9,784	$55.30	$541,055.20	907,836
1/16/2024	Muthusamy Shanmugam	COO	Sell	5,000	$55.63	$278,150.00	927,620
1/12/2024	Meredith Cook	VP	Sell	250	$56.43	$14,107.50	37,049
12/18/2023	Muthusamy Shanmugam	COO	Sell	13,026	$52.44	$683,083.44	957,620
12/15/2023	Muthusamy Shanmugam	COO	Sell	11,974	$52.44	$627,916.56	970,646
12/11/2023	Meredith Cook	VP	Sell	250	$49.21	$12,302.50	37,299
11/16/2023	Muthusamy Shanmugam	COO	Sell	6,448	$51.66	$333,103.68	996,430
11/15/2023	Krista Davis	SVP	Sell	2,622	$53.81	$141,089.82	32,587
11/14/2023	Muthusamy Shanmugam	COO	Sell	22,095	$53.17	$1,174,791.15	1,010,525
10/18/2023	Muthusamy Shanmugam	COO	Sell	6,242	$57.78	$360,662.76	1,042,620
10/16/2023	Muthusamy Shanmugam	COO	Sell	13,063	$58.31	$761,703.53	1,057,620
10/13/2023	Muthusamy Shanmugam	COO	Sell	11,937	$57.58	$687,332.46	1,070,683
10/2/2023	Chad Gassert	SVP	Sell	20,000	$56.48	$1,129,600.00	293,226
9/18/2023	Muthusamy Shanmugam	COO	Sell	8,425	$61.64	$519,317.00	1,107,953
9/15/2023	Muthusamy Shanmugam	COO	Sell	16,242	$62.81	$1,020,160.02	1,116,378
9/1/2023	Chad Gassert	SVP	Sell	20,000	$64.70	$1,294,000.00	313,226
8/28/2023	Muthusamy Shanmugam	COO	Sell	25,000	$63.06	$1,576,500.00	1,157,620
8/23/2023	Ori Gutwerg	SVP	Sell	15,561	$62.39	$970,850.79	60,915
8/16/2023	Meridian Venture Partners Ii L	Major Shareholder	Sell	200,000	$58.50	$11,700,000.00	1,819,259
8/15/2023	Nikhil Lalwani	CEO	Sell	11,616	$61.13	$710,086.08	353,390
8/14/2023	Antonio R Pera	Director	Sell	3,000	$60.37	$181,110.00	33,627
8/14/2023	Muthusamy Shanmugam	COO	Sell	27,890	$61.15	$1,705,473.50	1,204,730
8/11/2023	Nikhil Lalwani	CEO	Sell	56,666	$57.75	$3,272,461.50	353,390
8/1/2023	Chad Gassert	SVP	Sell	20,000	$51.06	$1,021,200.00	333,226
7/21/2023	Muthusamy Shanmugam	COO	Sell	11,500	$52.56	$604,440.00	1,232,620
7/19/2023	Muthusamy Shanmugam	COO	Sell	5,969	$51.48	$307,284.12	1,250,120
7/17/2023	Muthusamy Shanmugam	COO	Sell	9,831	$51.06	$501,970.86	1,262,789
7/14/2023	Muthusamy Shanmugam	COO	Sell	10,000	$50.43	$504,300.00	1,272,620
7/3/2023	Chad Gassert	SVP	Sell	20,000	$53.43	$1,068,600.00	353,226
6/22/2023	Chad Gassert	SVP	Sell	20,000	$51.32	$1,026,400.00	373,226
6/22/2023	Muthusamy Shanmugam	COO	Sell	13,500	$51.38	$693,630.00	7,407
6/20/2023	Muthusamy Shanmugam	COO	Sell	14,657	$51.93	$761,138.01	32,750
8/15/2022	James G Marken	SVP	Sell	5,172	$37.79	$195,449.88	117,642
8/12/2022	James G Marken	SVP	Sell	12,894	$37.04	$477,593.76	122,814
3/21/2022	Nikhil Lalwani	CEO	Buy	7,224	$27.69	$200,032.56
3/21/2022	Patrick D. Walsh	Director	Buy	5,000	$27.76	$138,800.00
3/17/2022	Muthusamy Shanmugam	COO	Buy	5,000	$27.65	$138,250.00
12/20/2021	Jeanne Thoma	Director	Buy	1,072	$46.47	$49,815.84
12/6/2021	Thomas Haughey	Director	Buy	2,500	$39.38	$98,450.00

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

SEC Filings (Institutional Ownership Changes) for ANI Pharmaceuticals (NASDAQ:ANIP)

76.05% of ANI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ANI Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Hohimer Wealth Management LLC	4,423	$0.26M	0.1%	N/A	0.021%
11/16/2024	Geode Capital Management LLC	425,225	$25.37M	0.0%	+4.2%	2.021%
11/15/2024	Barclays PLC	143,033	$8.53M	0.0%	+1,681.2%	0.680%
11/15/2024	Y Intercept Hong Kong Ltd	6,781	$0.41M	0.0%	N/A	0.032%
11/15/2024	Jane Street Group LLC	19,976	$1.19M	0.0%	-23.9%	0.095%
11/15/2024	Wellington Management Group LLP	9,411	$0.56M	0.0%	-78.4%	0.045%
11/15/2024	State Street Corp	703,843	$41.99M	0.0%	+9.1%	3.345%
11/15/2024	Stifel Financial Corp	6,999	$0.42M	0.0%	N/A	0.033%
11/15/2024	Janus Henderson Group PLC	9,510	$0.57M	0.0%	+83.7%	0.045%
11/15/2024	Hotchkis & Wiley Capital Management LLC	52,080	$3.11M	0.0%	N/A	0.248%
11/15/2024	HighTower Advisors LLC	3,613	$0.22M	0.0%	N/A	0.017%
11/14/2024	Martingale Asset Management L P	34,740	$2.07M	0.0%	+65.3%	0.165%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	33,951	$2.03M	0.0%	-21.0%	0.161%
11/14/2024	Public Sector Pension Investment Board	35,229	$2.10M	0.0%	+4.4%	0.167%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	2,971	$0.18M	0.0%	+24.2%	0.014%
11/13/2024	Rubric Capital Management LP	56,671	$3.38M	0.1%	-90.6%	0.269%
11/13/2024	BNP Paribas Financial Markets	7,930	$0.47M	0.0%	-4.4%	0.038%
11/13/2024	FMR LLC	18,401	$1.10M	0.0%	+27.5%	0.087%
11/13/2024	Advantage Alpha Capital Partners LP	5,772	$0.34M	0.1%	N/A	0.027%
11/13/2024	The Manufacturers Life Insurance Company	9,291	$0.55M	0.0%	-2.2%	0.044%
11/13/2024	Bank of Montreal Can	221,896	$13.04M	0.0%	N/A	1.055%
11/13/2024	Loomis Sayles & Co. L P	174,617	$10.42M	0.0%	-3.8%	0.830%
11/12/2024	Eagle Asset Management Inc.	35,630	$2.19M	0.0%	N/A	0.169%
11/12/2024	Charles Schwab Investment Management Inc.	250,346	$14.94M	0.0%	+3.7%	1.190%
11/12/2024	Pacer Advisors Inc.	568,343	$33.91M	0.1%	+23,259.8%	2.701%
11/12/2024	Thompson Siegel & Walmsley LLC	230,159	$13.73M	0.2%	+17.6%	1.094%
11/9/2024	Intech Investment Management LLC	12,593	$0.75M	0.0%	N/A	0.060%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	13,470	$0.80M	0.0%	+99.8%	0.064%
11/8/2024	Global Alpha Capital Management Ltd.	536,450	$32.01M	2.1%	+1.8%	2.550%
11/8/2024	Segall Bryant & Hamill LLC	44,872	$2.68M	0.0%	+1.7%	0.213%
11/7/2024	Quest Partners LLC	9,893	$0.59M	0.1%	+141.1%	0.047%
11/7/2024	Thrivent Financial for Lutherans	13,028	$0.78M	0.0%	+2.3%	0.062%
11/6/2024	Natixis Advisors LLC	18,184	$1.09M	0.0%	+56.2%	0.086%
11/6/2024	Mizuho Markets Americas LLC	195,613	$11.67M	0.2%	N/A	0.930%
11/5/2024	Victory Capital Management Inc.	12,919	$0.77M	0.0%	+153.6%	0.061%
11/4/2024	Lisanti Capital Growth LLC	14,920	$0.89M	0.2%	-70.8%	0.071%
11/4/2024	Los Angeles Capital Management LLC	21,474	$1.28M	0.0%	-6.5%	0.102%
11/1/2024	Summit Global Investments	19,704	$1.18M	0.1%	+154.2%	0.094%
10/31/2024	Principal Financial Group Inc.	89,961	$5.37M	0.0%	+6.9%	0.429%
10/29/2024	F M Investments LLC	61,782	$3.69M	0.1%	N/A	0.295%
10/29/2024	James Investment Research Inc.	4,075	$0.24M	0.0%	N/A	0.019%
10/28/2024	Rice Hall James & Associates LLC	60,375	$3.60M	0.2%	-0.5%	0.288%
10/25/2024	New York State Teachers Retirement System	24,120	$1.44M	0.0%	+1.7%	0.115%
10/25/2024	China Universal Asset Management Co. Ltd.	4,045	$0.24M	0.0%	+64.2%	0.019%
10/24/2024	State of Alaska Department of Revenue	9,467	$0.56M	0.0%	+5.2%	0.045%
10/23/2024	Louisiana State Employees Retirement System	8,000	$0.48M	0.0%	+3.9%	0.038%
10/23/2024	Assenagon Asset Management S.A.	186,179	$11.11M	0.0%	+149.7%	0.888%
10/19/2024	Allspring Global Investments Holdings LLC	21,731	$1.30M	0.0%	-4.5%	0.104%
10/11/2024	Wedge Capital Management L L P NC	58,682	$3.50M	0.1%	-5.3%	0.279%
10/10/2024	Exchange Traded Concepts LLC	12,056	$0.72M	0.0%	+20.8%	0.057%
10/10/2024	Kings Path Partners LLC	19,418	$1.16M	0.5%	+18.9%	0.093%
8/16/2024	Algert Global LLC	12,951	$0.83M	0.0%	-64.6%	0.062%
8/15/2024	Susquehanna Fundamental Investments LLC	3,588	$0.23M	0.0%	N/A	0.017%
8/15/2024	The Manufacturers Life Insurance Company	9,498	$0.61M	0.0%	+14.6%	0.045%
8/15/2024	Millennium Management LLC	230,079	$14.65M	0.0%	+1,005.8%	1.097%
8/15/2024	Marathon Capital Management	70,295	$4.48M	1.1%	-1.2%	0.335%
8/15/2024	Maverick Capital Ltd.	18,536	$1.18M	0.0%	+302.1%	0.088%
8/15/2024	Deerfield Management Company L.P. Series C	5,138	$0.33M	0.0%	+11.0%	0.024%
8/15/2024	AQR Capital Management LLC	17,527	$1.12M	0.0%	+44.8%	0.084%
8/14/2024	Marshall Wace LLP	3,979	$0.25M	0.0%	N/A	0.019%
8/14/2024	Public Sector Pension Investment Board	33,729	$2.15M	0.0%	+7.8%	0.161%
8/14/2024	ProShare Advisors LLC	3,570	$0.23M	0.0%	-19.7%	0.017%
8/14/2024	Profund Advisors LLC	3,536	$0.23M	0.0%	N/A	0.017%
8/13/2024	Rubric Capital Management LP	603,800	$38.45M	1.0%	-37.0%	2.879%
8/13/2024	Thrivent Financial for Lutherans	12,729	$0.81M	0.0%	-2.7%	0.061%
8/13/2024	Sei Investments Co.	14,473	$0.92M	0.0%	+27.8%	0.069%
8/12/2024	XTX Topco Ltd	3,254	$0.21M	0.0%	N/A	0.016%
8/12/2024	Amalgamated Bank	4,561	$0.29M	0.0%	-4.3%	0.022%
8/9/2024	Renaissance Technologies LLC	156,802	$9.99M	0.0%	+15.4%	0.748%
8/9/2024	Dimensional Fund Advisors LP	630,226	$40.13M	0.0%	+3.5%	3.005%
8/9/2024	Thompson Siegel & Walmsley LLC	195,743	$12.47M	0.2%	+1.5%	0.933%
8/8/2024	William Blair Investment Management LLC	489,386	$31.16M	0.1%	-0.2%	2.333%
8/8/2024	American Century Companies Inc.	99,831	$6.36M	0.0%	+99.2%	0.476%
8/8/2024	Rice Hall James & Associates LLC	60,672	$3.86M	0.2%	-6.4%	0.289%
8/7/2024	ClariVest Asset Management LLC	43,911	$2.80M	0.3%	-12.4%	0.209%
8/7/2024	Texas Permanent School Fund Corp	13,372	$0.85M	0.0%	+1.3%	0.064%
8/6/2024	Quest Partners LLC	4,104	$0.26M	0.0%	N/A	0.020%
8/6/2024	Great Lakes Advisors LLC	56,081	$3.57M	0.0%	+10.6%	0.267%
8/6/2024	Los Angeles Capital Management LLC	22,974	$1.46M	0.0%	-8.0%	0.110%
8/6/2024	Wakefield Asset Management LLLP	13,986	$0.89M	0.3%	-1.2%	0.067%
8/5/2024	Arizona State Retirement System	4,702	$0.30M	0.0%	+4.7%	0.022%
8/5/2024	Victory Capital Management Inc.	5,094	$0.32M	0.0%	-25.4%	0.024%
8/1/2024	Rhumbline Advisers	42,170	$2.69M	0.0%	+15.4%	0.201%
8/1/2024	Natixis Advisors LLC	11,639	$0.74M	0.0%	N/A	0.056%
8/1/2024	Hussman Strategic Advisors Inc.	42,000	$2.68M	0.7%	+33.3%	0.200%
8/1/2024	Lisanti Capital Growth LLC	51,105	$3.25M	0.8%	+59.3%	0.244%
7/31/2024	Commonwealth Equity Services LLC	12,114	$0.77M	0.0%	-5.8%	0.058%
7/30/2024	Kings Path Partners LLC	16,332	$1.04M	0.5%	N/A	0.078%
7/29/2024	Principal Financial Group Inc.	84,132	$5.36M	0.0%	-4.1%	0.401%
7/29/2024	Innealta Capital LLC	1,025	$65K	0.0%	N/A	0.005%
7/29/2024	Panagora Asset Management Inc.	8,781	$0.56M	0.0%	-4.2%	0.042%
7/29/2024	Ridgewood Investments LLC	1,329	$85K	0.1%	N/A	0.006%
7/26/2024	Legato Capital Management LLC	7,440	$0.47M	0.1%	+62.8%	0.035%
7/26/2024	Allspring Global Investments Holdings LLC	22,751	$1.45M	0.0%	+6.9%	0.108%
7/26/2024	Bank of New York Mellon Corp	131,156	$8.35M	0.0%	+10.9%	0.625%
7/24/2024	Louisiana State Employees Retirement System	7,700	$0.49M	0.0%	+2.7%	0.037%
7/22/2024	Summit Global Investments	7,752	$0.49M	0.0%	-48.8%	0.037%
7/19/2024	BTC Capital Management Inc.	8,110	$0.52M	0.0%	-3.3%	0.039%
7/18/2024	Assenagon Asset Management S.A.	74,566	$4.75M	0.0%	-11.2%	0.356%
7/17/2024	Wedge Capital Management L L P NC	61,961	$3.95M	0.1%	-23.4%	0.295%

Data available starting January 2016

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $56.91

$55.99

$57.14

50 Day Range

MA: $58.34

$55.10

$61.74

52 Week Range

Now: $56.91

$48.20

$70.81

Volume

131,831 shs

Average Volume

282,775 shs

Market Capitalization

$1.20 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of ANI Pharmaceuticals?: ANI Pharmaceuticals' top insider shareholders include:
Meridian Venture Partners Ii L (Major Shareholder)
Muthusamy Shanmugam (COO)
Nikhil Lalwani (CEO)
Chad Gassert (SVP)
Stephen P Carey (CFO)
James G Marken (SVP)
Christopher Mutz (Insider)
Ori Gutwerg (SVP)
Meredith Cook (VP)
Antonio R Pera (Director)
Krista Davis (SVP)
Renee P Tannenbaum (Director)
Learn More about top insider investors at ANI Pharmaceuticals.
Who are the major institutional investors of ANI Pharmaceuticals?: ANI Pharmaceuticals' top institutional investors include:
State Street Corp — 3.35%
Pacer Advisors Inc. — 2.70%
Global Alpha Capital Management Ltd. — 2.55%
Geode Capital Management LLC — 2.02%
Charles Schwab Investment Management Inc. — 1.19%
Thompson Siegel & Walmsley LLC — 1.09%
Learn More about top institutional investors of ANI Pharmaceuticals stock.
Which major investors are selling ANI Pharmaceuticals stock?: Within the previous quarter, ANIP stock was sold by these institutional investors:
Rubric Capital Management LP
Lisanti Capital Growth LLC
Wellington Management Group LLP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Loomis Sayles & Co. L P
Jane Street Group LLC
Wedge Capital Management L L P NC
Los Angeles Capital Management LLC
Within the previous year, company insiders that have sold ANI Pharmaceuticals company stock include:
Meridian Venture Partners Ii L (Major Shareholder)
Muthusamy Shanmugam (COO)
Nikhil Lalwani (CEO)
Chad Gassert (SVP)
Stephen P Carey (CFO)
James G Marken (SVP)
Christopher Mutz (Insider)
Ori Gutwerg (SVP)
Meredith Cook (VP)
Learn More investors selling ANI Pharmaceuticals stock.
Which major investors are buying ANI Pharmaceuticals stock?: Within the last quarter, ANIP stock was purchased by institutional investors including:
Pacer Advisors Inc.
Bank of Montreal Can
Mizuho Markets Americas LLC
Barclays PLC
Assenagon Asset Management S.A.
F M Investments LLC
State Street Corp
Hotchkis & Wiley Capital Management LLC